Vaccines can only take us so far. Invivyd science breaks through biological limits to take us farther.

We are thrilled to announce that Invivyd is teaming up with pro football coach Jim Harbaugh to raise awareness of the continuing toll of COVID-19 in America.

abstract coach Jim Harbaugh

Invivyd is improving lives with medicines for serious infectious diseases.

Artist’s 3D interpretation of an antibody-based therapy developed to address an evolving viral threat

Our Extraordinary Technology

Invivyd creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, develop, and adapt to create best in class antibodies.

More
Artist’s 3D interpretation of an antibody-based therapy developed to address an evolving viral threat

Our Pipeline

We are generating a robust pipeline of monoclonal antibody candidates, which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications.

More
Three colleagues meeting to discuss the antibody-based therapies they’re developing to address evolving viral threats Two scientists in a lab working to develop antibody-based therapies to address evolving viral threats

Join Our Team

We are united by a shared commitment to protecting the most vulnerable people in our communities from today’s and tomorrow’s serious viral threats. To address evolving viral threats, we have created a culture that embraces change, nimble decision making, and the relentless pursuit of our mission.

More